Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed H Abdel-Rahman

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Fitoterapia|September 10, 2011
In vitro anti-uveal melanoma activity of phenolic compounds from the Egyptian medicinal plant Acacia niloticaManar M Salem, Frederick H Davidorf, Mohamed H Abdel-Rahman
International Journal of Clinical Oncology|September 11, 2025
Longitudinal nationwide analysis of uveal melanoma in the United States1995-2018Ahmad Samir Alfaar, Mohamed H Abdel-Rahman, Moataz Hamed Osman
Biochimica Et Biophysica Acta. Reviews on Cancer|January 22, 2025
An overview of BAP1 biological functions and current therapeuticsAbdelrahman M Elsayed, Muaiad Kittaneh, Colleen M Cebulla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Expression of vascular endothelial growth factor in uveal melanoma is independent of 6p21-region copy numberMohamed H Abdel-Rahman, Elson L Craig, Frederick H Davidorf, et al.
Familial Cancer|March 17, 2026
Patient-derived outcome assessment of knowledge, communication, and management in those diagnosed with BAP1-tumor predisposition syndromeKelley Godwin, Joseph McElroy, Leigha Senter, et al.
Familial Cancer|January 11, 2016
Germline BAP1 mutations misreported as somatic based on tumor-only testingMohamed H Abdel-Rahman, Karan Rai, Robert Pilarski, et al.
Investigative Ophthalmology & Visual Science|February 19, 2010
MET oncogene inhibition as a potential target of therapy for uveal melanomasMohamed H Abdel-Rahman, Getachew Boru, James Massengill, et al.
American Journal of Ophthalmology|December 14, 2020
Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of RiskNakul Singh, Rahul Singh, Randy Chris Bowen, et al.
Cancer Genetics|May 21, 2018
Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinomaAsmaa Mosbeh, Khalil Halfawy, Wael S Abdel-Mageed, et al.
Familial Cancer|November 13, 2010
Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predispositionMohamed H Abdel-Rahman, Robert Pilarski, James B Massengill, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Fitoterapia|September 10, 2011
In vitro anti-uveal melanoma activity of phenolic compounds from the Egyptian medicinal plant Acacia niloticaManar M Salem, Frederick H Davidorf, Mohamed H Abdel-Rahman
International Journal of Clinical Oncology|September 11, 2025
Longitudinal nationwide analysis of uveal melanoma in the United States1995-2018Ahmad Samir Alfaar, Mohamed H Abdel-Rahman, Moataz Hamed Osman
Biochimica Et Biophysica Acta. Reviews on Cancer|January 22, 2025
An overview of BAP1 biological functions and current therapeuticsAbdelrahman M Elsayed, Muaiad Kittaneh, Colleen M Cebulla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Expression of vascular endothelial growth factor in uveal melanoma is independent of 6p21-region copy numberMohamed H Abdel-Rahman, Elson L Craig, Frederick H Davidorf, et al.
Familial Cancer|March 17, 2026
Patient-derived outcome assessment of knowledge, communication, and management in those diagnosed with BAP1-tumor predisposition syndromeKelley Godwin, Joseph McElroy, Leigha Senter, et al.
Familial Cancer|January 11, 2016
Germline BAP1 mutations misreported as somatic based on tumor-only testingMohamed H Abdel-Rahman, Karan Rai, Robert Pilarski, et al.
Investigative Ophthalmology & Visual Science|February 19, 2010
MET oncogene inhibition as a potential target of therapy for uveal melanomasMohamed H Abdel-Rahman, Getachew Boru, James Massengill, et al.
American Journal of Ophthalmology|December 14, 2020
Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of RiskNakul Singh, Rahul Singh, Randy Chris Bowen, et al.
Cancer Genetics|May 21, 2018
Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinomaAsmaa Mosbeh, Khalil Halfawy, Wael S Abdel-Mageed, et al.
Familial Cancer|November 13, 2010
Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predispositionMohamed H Abdel-Rahman, Robert Pilarski, James B Massengill, et al.
Pageof 6